Life science CEOs see future in technology, disruption

Dive Brief:

• Life sciences CEOs are actively pursuing disruption in their industries, and digital technologies are seen as the key to transformation, a new KPMG survey finds.
• A sweeping 86% of CEOs see their organizations as active disrupters, up from 72% last year, with 78% calling technology investment a strategic rather than tactical maneuver. Also, 43% plan to increase investment in disruption over the next three years to meet corporate growth goals.
• Leaders also are optimistic about realizing return on investment on technologies. Asked about investment in digital transformation, artificial intelligence and robotic process automation systems, 30% expect to see ROI within 12 months and 25% in one to three years.

Today's Sponsors

Today's Sponsor